Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.

Antillón M, Bilcke J, Paltiel AD, Pitzer VE.

Vaccine. 2017 Jun 14;35(27):3506-3514. doi: 10.1016/j.vaccine.2017.05.001. Epub 2017 May 17.

2.

The burden of typhoid fever in low- and middle-income countries: A meta-regression approach.

Antillón M, Warren JL, Crawford FW, Weinberger DM, Kürüm E, Pak GD, Marks F, Pitzer VE.

PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376. doi: 10.1371/journal.pntd.0005376. eCollection 2017 Feb.

3.

A prospective study of the importance of enteric fever as a cause of non-malarial febrile illness in patients admitted to Chittagong Medical College Hospital, Bangladesh.

Maude RR, Ghose A, Samad R, de Jong HK, Fukushima M, Wijedoru L, Hassan MU, Hossain MA, Karim MR, Sayeed AA, van den Ende S, Pal S, Zahed AS, Rahman W, Karnain R, Islam R, Tran DT, Ha TT, Pham AH, Campbell JI, van Doorn HR, Maude RJ, van der Poll T, Wiersinga WJ, Day NP, Baker S, Dondorp AM, Parry CM, Faiz MA.

BMC Infect Dis. 2016 Oct 13;16(1):567.

4.

Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever.

Azmatullah A, Qamar FN, Thaver D, Zaidi AK, Bhutta ZA.

J Glob Health. 2015 Dec;5(2):020407. doi: 10.7189/jogh.05.020407. Review.

5.

Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM.

Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15. Review.

6.

Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.

McArthur MA, Fresnay S, Magder LS, Darton TC, Jones C, Waddington CS, Blohmke CJ, Dougan G, Angus B, Levine MM, Pollard AJ, Sztein MB.

PLoS Pathog. 2015 May 22;11(5):e1004914. doi: 10.1371/journal.ppat.1004914. eCollection 2015 May.

7.

Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review.

Mogasale V, Desai SN, Mogasale VV, Park JK, Ochiai RL, Wierzba TF.

PLoS One. 2014 Apr 17;9(4):e93784. doi: 10.1371/journal.pone.0093784. eCollection 2014. Review.

8.

Risk factors for the development of severe typhoid fever in Vietnam.

Parry CM, Thompson C, Vinh H, Chinh NT, Phuong le T, Ho VA, Hien TT, Wain J, Farrar JJ, Baker S.

BMC Infect Dis. 2014 Feb 10;14:73. doi: 10.1186/1471-2334-14-73.

9.

25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal.

Bajracharya D, Khan MI, Pach A 3rd, Shrestha P, Joshi N, Upreti SR, Wierzba T, Puri M, Sahastrabuddhe S, Ochiai RL.

PLoS One. 2014 Jan 6;9(1):e77974. doi: 10.1371/journal.pone.0077974. eCollection 2014.

10.

Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier state.

Saul A, Smith T, Maire N.

PLoS One. 2013 Sep 10;8(9):e74097. doi: 10.1371/journal.pone.0074097. eCollection 2013.

11.

Host-pathogen interaction in invasive Salmonellosis.

de Jong HK, Parry CM, van der Poll T, Wiersinga WJ.

PLoS Pathog. 2012;8(10):e1002933. doi: 10.1371/journal.ppat.1002933. Epub 2012 Oct 4. Review.

12.

Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization.

McArthur MA, Sztein MB.

PLoS One. 2012;7(6):e38408. doi: 10.1371/journal.pone.0038408. Epub 2012 Jun 5.

13.
14.

Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi.

Lindow JC, Fimlaid KA, Bunn JY, Kirkpatrick BD.

Infect Immun. 2011 Aug;79(8):3188-94. doi: 10.1128/IAI.05081-11. Epub 2011 May 31.

15.

Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan.

Owais A, Sultana S, Zaman U, Rizvi A, Zaidi AK.

Pediatr Infect Dis J. 2010 Nov;29(11):1035-9.

16.

Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates.

Cui C, Carbis R, An SJ, Jang H, Czerkinsky C, Szu SC, Clemens JD.

Clin Vaccine Immunol. 2010 Jan;17(1):73-9. doi: 10.1128/CVI.00266-09. Epub 2009 Nov 4.

17.

A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis.

Thaver D, Zaidi AK, Critchley J, Azmatullah A, Madni SA, Bhutta ZA.

BMJ. 2009 Jun 3;338:b1865. doi: 10.1136/bmj.b1865. Review.

18.

Controlled evaluation of Bactec Peds Plus/F and Bactec lytic/10 anaerobic/F media for isolation of Salmonella enterica serovars typhi and paratyphi A from blood.

Reller ME, Zaidi AK, Sultana S, Azeem S, Hanif B, Qureshi S, Hasan R, Bhutta Z, Akhter R, Goldmann DA.

J Clin Microbiol. 2009 Jan;47(1):245-6. doi: 10.1128/JCM.01452-08. Epub 2008 Nov 12.

19.

Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005.

Crump JA, Ram PK, Gupta SK, Miller MA, Mintz ED.

Epidemiol Infect. 2008 Apr;136(4):436-48. Epub 2007 Aug 9. Review.

20.

Current concepts in the diagnosis and treatment of typhoid fever.

Bhutta ZA.

BMJ. 2006 Jul 8;333(7558):78-82. Review. No abstract available.

Supplemental Content

Support Center